Neuvotion is developing breakthrough solutions for facilitating and restoring movement. Our approach combines targeted neurostimulation and AI (artificial intelligence) to deliver unparalleled therapeutic value for patients with a movement disorder or impairment from stroke or injury. Neuvotion products allow doctors and therapists to leverage state-of-the-art technology, while monitoring patient progress in-person or remotely.
External link for Neuvotion, Inc.
2 Leeds Ln
Darien, Connecticut 06820, US
Manhasset, NY 11030, US
Dave was instrumental in Neuvotion’s recent FDA clearance and incredible team player and member! We expect this year to be an even bigger one for Neuvotion!
Product Development expert with 45 years of expertise in consumer, industrial, and medical device product development.
I’m happy to share that I’m starting a new position as Chief Operating Officer at Neuvotion, Inc.!
This content isn’t available here
Access this content and more in the LinkedIn app
Our own Chad Bouton speaks at Future of Care 2025 this week! Please follow!!
🔴 Future of Care 2025 is ONE WEEK AWAY! So begins a countdown of posts leading up to the conference highlighting the last leg of speakers and the content of each of the sessions as we ramp up excitement for the day of! This round of health tech thought leaders and active innovators includes: -> Meredith Oppenheim, Founder of Vitality Society -> Rohan Jotwani MD, MBA, Co-Director of the Extended Reality Anesthesiology Lab at Weill Cornell Medicine -> Olivier Elemento, Director of the Englander Institute for Precision Medicine -> Chad Bouton, VP of Advanced Engineering, The Feinstein Institutes and Founder, Neuvotion, Inc. Each of these speakers will bring their expertise and vision to the Caspary Auditorium stage and share what they envision the Future of Care will be. #healthtech #Innovation #medtech #biotech #interdisiplinary #FOC25 #FutureofCare #NYC
Thanks for the great mention, Liz Moyles on our FDA clearance!
Connecting MedTech and Medical Devices Cutting Edge Start Ups & Scale Ups to Relevant Investors to help inject capital and drive growth ! Championing this industry with passion!
🌸 WEEKLY ROUND UP- VALENTINE'S WEEK 💖 "Roses are Red, Violets are Blue, MedTech is Great and So are YOU!" 🥰 Ok so I am definitely not a poet, but things have been rosy again this week & Valentine struck early for some. 👏 Congratulations superstars & sorry to those I missed. Happy Belated Valentine’s Day everyone! So let’s get in there and dig out some headlines! 📰IN THE NEWS 📰 Johnson & Johnson to sell Cerenovous for $1Bn & also launched the CereGlide 92 catheter system Nanovis sold certain nano surface technology assets & IP rights to Medtronic-Brian More Carmat achieved 100 implants of Aeson-its artificial heart- 100 lives saved! Stephane Piat, Pierre Bastid, Laurent Kirsch Plexāā | Creators of BLOOM⁴³ secured a manufacturing deal for Bloom-Saahil Mehta The Royal Marsden Hospital Trust became the 1st UK hospital with Symani MMI - Medical Microinstruments, Inc. Mark Toland Ziwig Biotech secured fast-track reimbursement for Ziwig Endotest-Yahya EL MIR Creo Medical completed the sale of 51% of its European arm to Micro-Tech (NL) International B.V-Craig Gulliford SpineGuard launched “PsiFGuard” for Sacroiliac Joint Fusion- Pierre Jerome, Stephane Bette, 💃 💲 RAISERS, MOVERS AND SHAKERS 💰 Nina Capital closed a €50M third fund, for pre-seed to series A healthtech's, (EU,USA, Canada, Israel,Australia)-Marta-Gaia Zanchi, Swizzle Ventures announced a $6.6M Fund, for women’s health & other interests for USA pre-seed to seeds-Jessica Kamada, Ashley Lieser NeuroPace announced a $65M public stock offering-Joel Becker Paradromics Inc. received an investment from NEOM,Saudi Arabia- Matt Angle Epicore Biosystems raised $26M Series B- Steve Murphy Newronika S.p.A. closed a $14.1M Series B-Dr. Lorenzo Rossi Levee Medical, Inc. closed a Series B at $14M-Adam Irving, Bruce Choi Microbot Medical issued a Public Stock Offering circa $13M-Harel Gadot Exero Medical closed a $12.7M preferred seed financing Scanvio Medical received CHF150,000 for Scanvio Assist-Stefan Tuchschmid CoreMedic received new funding Series B-Josef Bogenschütz Mark Toland joins the board of directors Horizon Surgical Systems Bertrand Weil joins the Supervisory Board of Microsure ForSight Robotics appoints Dr. Fred Moll to Director's Board, Yonatan Ushpizin as VP of R&D & Ilanit Edri as VP People-Joseph Nathan Adrian Lam, CFA appointed President and CEO CorVista Health Paige Ritchie promoted to VP Sales Rad AI ✅ 🎖️ FDA, CE MARKS, FIH AND MORE !! 🥁 Neuvotion, Inc. received FDA clearance for NeuStim-Chad Bouton, Rory Murphy Jupiter Endovascular completed a 1st procedure enrolling its 1st patient to SPIRARE II pivotal trial-Carl St. Bernard Wellumio enrolled its 1st patient in Australian clinical trial of Axana 0.1T- Shieak Tzeng Symphony Robotics licensed Case Western Reserve University (CWRU)’s robotic platform to develop & commercialise it -Mordechai (Moty) Avisar …and that is a wrap. Have a wonderful next week-all the best! Liz
Incredibly excited to share Neuvotion has received FDA clearance for its first product, NeuStim(TM)!!! We founded Neuvotion with the vision of bringing easy-to-use, high performance neurostimulation in a wearable form for hand movement recovery after stroke or injury. NeuStim(TM) has over 100 small electrodes in an advanced flexible array that can rapidly pinpoint motor points and evoke individual finger movements, based on years of research and the team’s incredible efforts. A version in development also utilizes AI to infer the user’s intentions to ‘replay’ stimulation patterns for various hand motions and grasping to increase user independence for activities of daily living. Congratulations to all that made this possible! https://lnkd.in/eWrPnH6B
You guys have been incredible to work with!!
We’re proud to partner with Neuvotion, Inc. as they commercialize their first product, NeuStim™—a pioneering technology that leverages AI-driven neuromodulation to transform stroke and spinal cord injury recovery. With our multidisciplinary engineering and medical device design expertise, IPS is helping Neuvotion accelerate the path to market and improve patient outcomes. This expanded partnership represents a critical step forward in neurorehabilitation, and we’re thrilled to play a part in it. 🔗 Learn more: https://lnkd.in/epg_BCDx #Innovation #Neurotech #Medtech #EngineeringExcellence #PatientCare
Neuvotion, Inc. reposted this
Reeve Summit 2025 is your chance to connect, learn, and collaborate on solutions for a more inclusive future. Join individuals living with paralysis, caregivers, healthcare providers, and experts to tackle these challenges together. Register now! https://lnkd.in/ggU5iy2
Amazing team with incredible knowledge, experience, and compassion!
The primary objective of a new study Good Shepherd Rehabilitation is participating in is to use Neuvotion's new investigational (transcutaneous) neuromuscular electrical stimulation device, called NeuStimTM, to evoke and assess functional grasping in individuals following spinal cord injury or stroke. Occupational therapists Kathryn Karoly, Gail Metzger and Carly Haffner will be the first at Good Shepherd to use this device in a research setting. In addition to characterizing the ability of the device to produce hand movements, they are testing the proprietary Glide Path technology that uses AI to recognize arm motions and enable user-driven functional grasping. Dr. Sandeep Singh MD FAAPMR, Good Shepherd's Chief Medical Officer, is the Principal Investigator and Rhonda Tucker is the Clinical Researcher. The study is scheduled to begin this winter. . . . Neuvotion, Inc. Chad Bouton
Happy Thanksgiving and holidays to everyone! We are so thankful for our supporters, partners, collaborators, and future users. We are grateful for your help and feedback as we strive to advance the fields of neurotechnology and neurorehabilitation! Good Shepherd Rehabilitation, Northwell Health, Northwell Holdings, Intelligent Product Solutions, Forward Industries, and many more!
Clinical studies in the neuromodulation field continue to demonstrate positive outcomes and we won’t stop pushing towards new treatment options for the millions living with movement impairment after stroke and injury. Thanks to our team, partners and everyone supporting our efforts!
So grateful for my incredible team, collaborators, participants, family, friends and our new friends and NBC News correspondent, Sam Brock, (the tall one)!! New things in development and we won't stop working towards new treatments for #paralysis and pushing boundaries in #BCI #bioelectronicmedicine #bioelectronics #neurotechnology #neuromodulation Keith Thomas, Michelle Thomas, Santosh Chandrasekaran Zeev Elias Erona Ibroçi Sarah Kim Wandelt Aniket Jangam Isabelle Rosenthal @christina Maffei Dana Fried and Matthew Libassi ! and many more!!
The foundational science and research continues to progress with astounding results! Neuvotion salutes the participants and teams behind it all!
So incredibly proud to share our participant's and team's progress! Keith is now grasping and feeling, and is even sustaining new sensation below his injury level -- even after we turn off his #doubleneuralbypass and he goes home. Keith is an incredible pioneer in the #braincomputerinterface race and field and is an inspiration to all of us as we continue to develop new technologies and treatments for #paralysis! Congrats to the team!! Santosh Chandrasekaran Erona Ibroçi, MPH Ashesh Mehta Stephan Bickel Netanel (Nati) Ben-Shalom MD, FNPS Zeev Elias Aniket Jangam Sarah Kim Wandelt Isabelle Rosenthal Jose Herrero Matthew Libassi Emily Ng Northwell Health Northwell Holdings The Feinstein Institutes